FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912893185> ?p ?o ?g. }

• W2912893185 endingPage "1029" @default.
• W2912893185 startingPage "1023" @default.
• W2912893185 abstract "POEMS syndrome is a rare plasma cell dyscrasia. This study compared the responses to and survival of 347 POEMS syndrome patients given three first-line treatment regimens: autologous stem cell transplantation (ASCT, N = 165) and melphalan + dexamethasone (MDex, N = 79), or lenalidomide + dexamethasone (LDex, N = 103). After a median 45-month follow-up, overall hematologic complete remission (CRH) was 46.4%, vascular endothelial growth factor complete remission (CRV) was 55.1%, and neurological remission (RN) was 93.8%. CRH was better with ASCT (49.7%) than with MDex (37.7%, p = 0.001). CRV was better with ASCT (66.2%) than with MDex (38.5%, p = 0.001) or LDex (47.7%, p = 0.008). Differences in RN achieved by three regimens (91.5% vs. 100% vs. 93.8%, p = 0.234) were not significant. Overall 3-year progression-free survival (PFS) was 80.5% and overall 3-year overall survival (OS) was 90.8%. PFS was 87.6% with ASCT and 64.9% with LDex (p = 0.003). OS in the three regimens did not differ (p = 0.079). In medium-high risk patients, ASCT had better CRH and CRV than MDex, and better PFS than LDex. Therefore, although all three treatments had reasonable responses and survivals, patients with higher risk may benefit more from ASCT treatment." @default.
• W2912893185 created "2019-02-21" @default.
• W2912893185 creator A5026844112 @default.
• W2912893185 creator A5036628942 @default.
• W2912893185 creator A5044757881 @default.
• W2912893185 creator A5052883326 @default.
• W2912893185 creator A5055407864 @default.
• W2912893185 creator A5062050521 @default.
• W2912893185 creator A5064794027 @default.
• W2912893185 creator A5073109278 @default.
• W2912893185 creator A5082551912 @default.
• W2912893185 date "2019-01-30" @default.
• W2912893185 modified "2023-10-14" @default.
• W2912893185 title "What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?" @default.
• W2912893185 cites W1982154014 @default.
• W2912893185 cites W2013802257 @default.
• W2912893185 cites W2033793452 @default.
• W2912893185 cites W2043590047 @default.
• W2912893185 cites W2061108137 @default.
• W2912893185 cites W2077646176 @default.
• W2912893185 cites W2128084036 @default.
• W2912893185 cites W2135609466 @default.
• W2912893185 cites W2170711889 @default.
• W2912893185 cites W2327395669 @default.
• W2912893185 cites W2425909334 @default.
• W2912893185 cites W2463081131 @default.
• W2912893185 cites W2576169474 @default.
• W2912893185 cites W2735307731 @default.
• W2912893185 cites W2766437971 @default.
• W2912893185 cites W2773758956 @default.
• W2912893185 cites W2774519283 @default.
• W2912893185 cites W2787298741 @default.
• W2912893185 cites W2794926294 @default.
• W2912893185 cites W2795996976 @default.
• W2912893185 cites W2796381757 @default.
• W2912893185 doi "https://doi.org/10.1038/s41375-019-0391-2" @default.
• W2912893185 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6756085" @default.
• W2912893185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30700844" @default.
• W2912893185 hasPublicationYear "2019" @default.
• W2912893185 type Work @default.
• W2912893185 sameAs 2912893185 @default.
• W2912893185 citedByCount "39" @default.
• W2912893185 countsByYear W29128931852019 @default.
• W2912893185 countsByYear W29128931852020 @default.
• W2912893185 countsByYear W29128931852021 @default.
• W2912893185 countsByYear W29128931852022 @default.
• W2912893185 countsByYear W29128931852023 @default.
• W2912893185 crossrefType "journal-article" @default.
• W2912893185 hasAuthorship W2912893185A5026844112 @default.
• W2912893185 hasAuthorship W2912893185A5036628942 @default.
• W2912893185 hasAuthorship W2912893185A5044757881 @default.
• W2912893185 hasAuthorship W2912893185A5052883326 @default.
• W2912893185 hasAuthorship W2912893185A5055407864 @default.
• W2912893185 hasAuthorship W2912893185A5062050521 @default.
• W2912893185 hasAuthorship W2912893185A5064794027 @default.
• W2912893185 hasAuthorship W2912893185A5073109278 @default.
• W2912893185 hasAuthorship W2912893185A5082551912 @default.
• W2912893185 hasBestOaLocation W29128931851 @default.
• W2912893185 hasConcept C126322002 @default.
• W2912893185 hasConcept C141071460 @default.
• W2912893185 hasConcept C143998085 @default.
• W2912893185 hasConcept C159654299 @default.
• W2912893185 hasConcept C203014093 @default.
• W2912893185 hasConcept C2775892965 @default.
• W2912893185 hasConcept C2776063141 @default.
• W2912893185 hasConcept C2776210965 @default.
• W2912893185 hasConcept C2776364478 @default.
• W2912893185 hasConcept C2777408962 @default.
• W2912893185 hasConcept C2778684742 @default.
• W2912893185 hasConcept C2779050716 @default.
• W2912893185 hasConcept C2779609412 @default.
• W2912893185 hasConcept C2780401358 @default.
• W2912893185 hasConcept C2780411336 @default.
• W2912893185 hasConcept C2911091166 @default.
• W2912893185 hasConcept C36394416 @default.
• W2912893185 hasConcept C71924100 @default.
• W2912893185 hasConcept C90924648 @default.
• W2912893185 hasConceptScore W2912893185C126322002 @default.
• W2912893185 hasConceptScore W2912893185C141071460 @default.
• W2912893185 hasConceptScore W2912893185C143998085 @default.
• W2912893185 hasConceptScore W2912893185C159654299 @default.
• W2912893185 hasConceptScore W2912893185C203014093 @default.
• W2912893185 hasConceptScore W2912893185C2775892965 @default.
• W2912893185 hasConceptScore W2912893185C2776063141 @default.
• W2912893185 hasConceptScore W2912893185C2776210965 @default.
• W2912893185 hasConceptScore W2912893185C2776364478 @default.
• W2912893185 hasConceptScore W2912893185C2777408962 @default.
• W2912893185 hasConceptScore W2912893185C2778684742 @default.
• W2912893185 hasConceptScore W2912893185C2779050716 @default.
• W2912893185 hasConceptScore W2912893185C2779609412 @default.
• W2912893185 hasConceptScore W2912893185C2780401358 @default.
• W2912893185 hasConceptScore W2912893185C2780411336 @default.
• W2912893185 hasConceptScore W2912893185C2911091166 @default.
• W2912893185 hasConceptScore W2912893185C36394416 @default.
• W2912893185 hasConceptScore W2912893185C71924100 @default.
• W2912893185 hasConceptScore W2912893185C90924648 @default.
• W2912893185 hasIssue "4" @default.
• W2912893185 hasLocation W29128931851 @default.

• next